ALB and pachyonychia congenita: In contrast to albumin bound drugs, such as nab‐paclitaxel, also called Abraxane, has been found dissociate rapidly due to the weak affinity between albumin and paclitaxel resulting in a limited therapeutic index.[34] Applying metronomic dosing may enhance antitumor activity,[41, 42] for example, changing dosing every three weeks to dosing weekly, however, the lack of an efficient target that is specific for PC tumors still remains absent for these formulated drugs.